GlobeNewswire

Cisco Doubles Down on Security Innovation and Investment to Protect the Endpoint and Email

Dela

Cisco Introduces New Email Security Services to More Effectively Prevent Phishing and Spoofing Attacks

 

SAN FRANCISCO, April 16, 2018 (GLOBE NEWSWIRE) -- RSA - Employees remain an organization's greatest asset however they can be a risk when it comes to cybersecurity. Attackers are crafting highly targeted, fraudulent emails that look legitimate and use them to deliver malware to unsuspecting users. When successful, it costs the majority of companies $500K or more in lost revenue, customers, opportunities, and out-of-pocket costs.1 To combat the rise of advanced threats targeting employees, Cisco is announcing new email security services to protect users from these fraudulent emails, as well as new capabilities to protect employees' devices from ransomware, cryptomining, and fileless malware.

Nearly all endpoint security solutions on the market claim to block 99 percent of malware. But what about the one percent of threats that evade detection using sophisticated techniques? Cisco® Advanced Malware Protection (AMP) for Endpoints, a cloud-managed endpoint security solution, prevents attacks and helps uncover the one percent of threats that can cripple a business. Cisco is adding a number of new capabilities to AMP for Endpoints, including:

  • Sophisticated detection and protection mechanisms to stop today's threats, including ransomware, and cryptomining: Cisco is now bolstering its threat protection even when a user is offline. The new AMP for Endpoints exploit prevention helps protect against fileless attacks, including those that reside solely in memory. Cisco AMP's new malicious activity protection stops ransomware execution, killing the processes and preventing propagation.
    • Cisco threat researchers analyzed ransomware variants to identify the common techniques used for encryption. The result: a new engine that continuously protects against ransomware encryption and propagation to keep businesses safe from ransomware.
    • Fileless malware has recently gained popularity in part because of the difficulty in detecting it. Built directly into the foundation of Cisco AMP is a new protection mechanism that requires no tuning or adjustments to stop these threats. It protects against unpatched software vulnerabilities and keeps working around the clock, even when users are offline. 
       
  • Threat investigation with Cisco Visibility, a new cloud application built into the endpoint console which simplifies and accelerates security investigations so security analysts can rapidly investigate incidents with confidence, quickly and at scale. It ingests, normalizes, and enriches security events and provides a visual representation of the extent of a compromise spanning from endpoints to network to cloud.
    • Cisco Visibility combines threat intelligence from Cisco Talos(TM) and third parties with internal security event and alert data from across an organization's security infrastructure to simplify investigations, reduce complexity, and shorten incident triage and remediation time.
    • Visibility minimizes the need to switch between multiple consoles to perform common tasks. With a few simple clicks, a user can dive deeper into the data from Talos, Cisco Umbrella Investigate(TM), Threat Grid, AMP, and other sources to quickly understand how observables exist in an environment and how they relate to each other.

Cisco invests in new email security services 
No matter how much the threat landscape changes, malicious email and spam remain vital tools for adversaries to distribute malware, and many of these threats reach the endpoint. Organizations must protect their own company domains from being misused as the delivery mechanism of malicious emails, as well as protect their internal users from phishing and spoofing attacks from emails with suspect senders.

Cisco is helping address these issues and more effectively prevent email identity deception used in phishing attacks. Cisco has concluded an OEM agreement with Agari to market and sell new services that enhance its Email Security product. The new email security services introduced include:

  • Cisco Domain Protection: Automates the process of using email authentication to prevent phishing, protect brands from fraud, and maintain email governance by analyzing, updating, and taking action against senders misusing their domain to send malicious email. This service uses Domain-Based Message Authentication, Reporting, and Conformance (DMARC), an email authentication standard, and real-time reporting back to domain users about noncompliant emails being sent from their domains. This will be a requirement for many organizations in the future, and as of October 2017, the U.S. Department of Homeland Security ordered federal agencies with .gov email domains to fully implement strict DMARC policies by October 2018.
  • Cisco Advanced Phishing Protection: Adds sophisticated machine learning capabilities to Cisco Email Security to block advanced identity deception attacks for inbound email by assessing its threat posture. It also uses both global and local telemetry data combined with analytics and modeling to validate the reputation and authenticity of senders. This helps organizations understand which emails carry targeted phishing and business email compromise (BEC) attacks so only legitimate emails reach an employee inbox.

Deployment through managed security services
To enable customers of all sizes to realize the benefits of these new capabilities, Cisco is expanding its relationship with ConnectWise so managed service providers (MSP) can offer Cisco Security as a part of their portfolio. The expanded relationship will offer the new ConnectWise Advanced Security Dashboard. This cloud management platform fully integrates with the ConnectWise Manage business management solution and complements ConnectWise Unite with Cisco, the existing portal for MSPs based on leading Cisco cloud-managed products. The new ConnectWise Advanced Security Dashboard provides MSPs with the ability to deliver managed security services with Cisco's security portfolio including Cisco AMP for Endpoints,  Cisco Umbrella, Cisco Stealthwatch® Cloud, Cisco Adaptive Security Appliances, Cisco Next-Generation Firewall, and Cisco Meraki® MX appliances.

"Cisco understands that protecting employees and their endpoints requires more than just antivirus. Attackers leverage the Internet, email, and the network as vectors for breaching the endpoint," said Jeff Reed, Senior Vice President of Product for Cisco's Security Business Group. "We deliver greater employee protection using cloud-delivered defense against threats hosted on the Internet. Cisco is also now one of the few organizations paving the way toward eliminating email identity deception. Through our expanded partnership, investments, and technology innovations, we are committed to delivering to our customers the best email and endpoint protection."

Supporting Resources:

About Cisco
Cisco (NASDAQ:CSCO) is the worldwide technology leader that has been making the Internet work since 1984. Our people, products, and partners help society securely connect and seize tomorrow's digital opportunity today. Discover more at newsroom.cisco.com and follow us on Twitter at @Cisco.

Cisco and the Cisco logo are trademarks or registered trademarks of Cisco and/or its affiliates in the U.S. and other countries. A listing of Cisco's trademarks can be found at www.cisco.com/go/trademarks. Third-party trademarks mentioned are the property of their respective owners. The use of the word partner does not imply a partnership relationship between Cisco and any other company. 

_________________________
1 Cisco Annual Cybersecurity Report 2018.

Press Relations 
Raquel Prieto 
408-527-3754 
raqpriet@cisco.com 

Analyst Relations
Jenna Duston 
408-424 7210 
jeabeyta@cisco.com 

Investor Relations
Marty Palka 
408-526 6635
mpalka@cisco.com 




This announcement is distributed by Nasdaq Corporate Solutions on behalf of Nasdaq Corporate Solutions clients.
The issuer of this announcement warrants that they are solely responsible for the content, accuracy and originality of the information contained therein.
Source: Cisco via Globenewswire

Om

GlobeNewswire



Följ GlobeNewswire

Abonnera på våra pressmeddelanden.

Senaste pressmeddelandena från GlobeNewswire

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Karolinska Development's portfolio company Modus Therapeutics completes enrollment in Phase II study with sevuparin7.1.2019 12:00Pressmeddelande

STOCKHOLM, January 7, 2019. Karolinska Development's portfolio company Modus Therapeutics announces that the patient enrollment has been completed in the Phase II study with sevuparin in patients with sickle cell disease (SCD). The results from the study is expected in mid 2019. Modus Therapeutic's randomized, double blind study contains 140 SCD-patients with Acute Vaso Occlusive Crisis (VOC). It compares intravenously administered sevuparin with placebo. The primary endpoint of the study is the demonstration of a reduced time to resolution of patient's VOC. Clincal sites across Europe and the Middle East took part in the study that was conducted in conjunction with Modus Therapeutics' co development partner Ergomed. SCD has a high unmet medical need as there are currently no approved therapies for VOCs. It is an inherited blood disorder that affects between 90,000 to 100,000 patients in the U.S. and is characterized by severely painful VOCs that lead to organ damage due to a lack of o

Stillfront Group rekryterar ansvarig för M&A19.12.2018 12:07Pressmeddelande

PRESSMEDDELANDE 19 december, 2018 Stillfront Group rekryterar ansvarig för M&A Stillfront Group, en marknadsledare inom 'free to play' online strategispel, annonserar idag att Marina Andersson har utsetts till ansvarig för M&A och kommer att ingå i koncernledningen. Marina har närmare tjugo års erfarenhet från investment banking och M&A. Hon har omfattande erfarenhet inom strategisk och finansiell rådgivning, affärsgenerering, projektledning inom förvärv och försäljningar av företag, finansiell analys, due diligence, samt företagsvärdering. Tidigare positioner inkluderar: Director, Deloitte's Corporate Finance Advisory team, Director, ICECAPITAL Securities, Associate Partner och Investment Manager, Deseven, samt M&A Analytiker på Carnegie. Marina har två magister-examen från Stockholms universitet och Russian Herzen State Pedagogical University. "Förvärv är en viktig del av Stillfronts affärsstrategi och vi är mycket glada att rekrytera Marina Andersson. Marinas breda erfarenhet och pr

Stillfront Group announces Head of M&A19.12.2018 12:07Pressmeddelande

PRESS RELEASE December 19, 2018 Stillfront Group announces Head of M&A Stillfront Group, a market leader in 'free to play' online strategy games, today announces that Marina Andersson has been appointed as Head of M&A and will be part of the Group's management team. Marina has close to 20 years track record of investment banking and M&A. She has extensive competence within strategic and financial advisory, deal generation, buy and sell side M&A project management, financial analysis, due diligence and company valuation. Former positions include: Director at Deloitte's Corporate Finance Advisory team, Director at ICECAPITAL Securities, Associate Partner and Investment Manager at Deseven, M&A Analyst at Carnegie. She holds two Master degrees from Stockholm University and Russian Herzen State Pedagogical University. "Acquisitions are a crucial part of Stillfront's business strategy and we are very pleased with the appointment of Marina Andersson. Marina's breadth of experience and profess

Oboya tecknar ett samarbetsavtal med Gaia avseende biomaterial13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") har tecknat ett viktigt och långsiktigt samarbetsavtal avseende miljövänligt biomaterial med Gaia Biomaterials AB ("Gaia") i Helsingborg, Sverige. Avtalet innebär att Oboya använder Gaias biomaterial för tillverkning och utveckling av miljövänliga odlingsprodukter till odlingsindustrin. Oboya har under de senaste åren arbetat aktivt med innovation, miljö- och hållbarhetsfrågor och vårt mål är att främja miljö och hållbarhet inom odlingsindustrin genom att erbjuda miljövänliga odlingsprodukter till våra kunder. Oboya anser att användningen av biomaterial kommer att vara viktigt för framgång i omställningen till en fossilfri odlingsindustri världen över. Samarbetsavtalet innebär att Oboya använder Gaias biomaterial i sin produktion och att vi genom Gaias kompetens kan utveckla nya miljövänliga odlingsprodukter. Gaias biomaterial är biologiskt nedbrytbart, komposterbart samt ger upp till 80 % lägre koldioxidutsläpp vid förbränning jämfört

Oboya signs a cooperation agreement with Gaia regarding biomaterials13.12.2018 11:41Pressmeddelande

Oboya Horticulture Industries AB (publ) ("Oboya") has signed an important and long-term cooperation agreement on environmentally friendly biomaterials with Gaia Biomaterials AB ("Gaia") in Helsingborg, Sweden. The agreement means that Oboya uses Gaias biomaterials for the production and development of environmentally friendly cultivation products for the cultivation industry. Oboya has been actively involved in innovation, environmental and sustainability issues in recent years, and our goal is to encourage environmental and sustainability in the cultivation industry by offering environmentally friendly cultivation products to our customers. Oboya believes that the use of biomaterials will be important for success in the conversion to a fossil-free cultivation industry worldwide. The cooperation agreement means that Oboya uses Gaias biomaterials in its production and that through Gaias expertise we can develop new environmentally friendly cultivation products. Gaias biomaterials are bi

I vårt pressrum kan du läsa de senaste pressmeddelandena, få tillgång till pressmaterial och hitta kontaktinformation.

Besök vårt pressrum